1. Completed
Loading page
SME
SME issue. Listed.
Source: IPO Guru Pro
Company information, issue size, price band, lot size, minimum investment, and the dates published for this issue.
Avience Biomedicals Limited was incorporated in 2019 as Avience Biomedicals Private Limited and was later converted into a public limited company. The company is promoted by Dharam Deo Choudhary, Ram Nagina Choudhary, Janardan Pal and Deepa Choudhary. Headquartered in New Delhi, the company has established itself in the healthcare diagnostics segment by focusing on quality-driven biomedical and diagnostic products. The company is engaged in the manufacturing and distribution of molecular diagnostic kits, reagents and related healthcare products used by hospitals, laboratories and diagnostic centres. Its business model is based on developing and supplying testing solutions that support disease detection and clinical diagnostics. With increasing demand for advanced healthcare testing infrastructure, the company aims to expand its product portfolio and market reach across India.
Current premium in rupees, the derived percentage, and the indicative price. History shows observed readings only. A missing premium is unavailable, not ₹0.
Grey Market Premium (GMP) is an unofficial market indicator and is not published by stock exchanges. Estimated listing values are illustrative, may change, and should not be considered a forecast or investment recommendation.
Indicative only. A GMP-implied price is not a guaranteed listing price.
Subscription is shown in times subscribed. A missing multiple stays unavailable. A published zero is 0x.
Last updated: Unavailable
Last updated: Unavailable
Source: IPO Guru Pro Data by IPO Guru
History retrieved: 05 Nov 2026, 5:45 PM IST
No day-wise subscription history is loaded. Missing days are left blank and are not plotted as zero.
Source: IPO Guru Pro. History retrieved 05 Nov 2026, 5:45 PM IST.
Revenue and profit are in rupees for each reporting period. Assets, liabilities, and ratios use the source unit when the statement includes them. Missing figures stay blank.
| Metric (Rs. Crore) | 31 Jan 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 66.07 | 56.52 | 34.65 |
| Total Income | 41.94 | 45.97 | 24.37 |
| Profit After Tax | 5.74 | 7.23 | 2.14 |
| EBITDA |
No verified registrar allotment link is stored, so Check Allotment stays disabled.
This is the actual change from the issue price to the listing price. It is separate from the unofficial GMP estimate. A missing price stays unavailable.
RHP, DRHP, and other links that passed the official address check. Unverified addresses are left out.
DRHP, RHP and other source documents appear here when the issue includes them.
Data by IPO Guru · Updated
Avience Biomedicals IPO was open for subscription from 18 June 2026 to 22 June 2026. Incorporated in 2019, Avience Biomedicals Limited is a molecular diagnostics and biomedical products company focused on healthcare testing solutions. The company follows a business model centred on manufacturing and supplying diagnostic kits, reagents and laboratory products for healthcare institutions. Based in Noida, the company serves hospitals, diagnostic laboratories and healthcare providers across India
Deepa Choudhary, Dharam Deo Choudhary, Janardan Pal and Ram Nagina Choudhary
1. Completed
2. Completed
3. Completed
4. Completed
Refund
Demat credit
Unofficial grey-market premium in rupees. Missing observations are not connected and are not drawn as ₹0. This chart is not the listing gain.
High unavailable · Low unavailable
Tap a point for its rupee amount, percentage, and IST time. The table lists the same observations.
Source: IPO Guru Pro. History retrieved 05 Nov 2026, 5:45 PM IST.
| Observed (IST) | GMP (₹) | GMP % | Mark |
|---|---|---|---|
| 25 Jun 2026, 8:00 AM IST | ₹145 | +69.71% | None |
No intraday GMP history is loaded. Missing slots are not filled in.
High unavailable · Low unavailable
Source: IPO Guru Pro. History retrieved 05 Nov 2026, 5:45 PM IST.
| 10.34 |
| 11.41 |
| 4.08 |
| NET Worth | 28.52 | 22.78 | 6.21 |
| Reserves and Surplus | 24.49 | 18.75 | 2.93 |
| Total Borrowing | 26.73 | 22.16 | 15.13 |